1 Market Overview

1.1 Product Overview and Scope of Circulating Tumor Cells

1.2 Classification of Circulating Tumor Cells by Type

1.2.1 Overview: Global Circulating Tumor Cells Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Circulating Tumor Cells Revenue Market Share by Type in 2021

1.2.3 CTC Enrichment

1.2.4 CTC Detection

1.2.5 CTC Analysis

1.3 Global Circulating Tumor Cells Market by Application

1.3.1 Overview: Global Circulating Tumor Cells Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Breast Cancer

1.3.3 Prostate Cancer

1.3.4 Colorectal Cancer

1.3.5 Lung Cancer

1.3.6 Others

1.4 Global Circulating Tumor Cells Market Size & Forecast

1.5 Global Circulating Tumor Cells Market Size and Forecast by Region

1.5.1 Global Circulating Tumor Cells Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Circulating Tumor Cells Market Size by Region, (2017-2022)

1.5.3 North America Circulating Tumor Cells Market Size and Prospect (2017-2028)

1.5.4 Europe Circulating Tumor Cells Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Circulating Tumor Cells Market Size and Prospect (2017-2028)

1.5.6 South America Circulating Tumor Cells Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Circulating Tumor Cells Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Circulating Tumor Cells Market Drivers

1.6.2 Circulating Tumor Cells Market Restraints

1.6.3 Circulating Tumor Cells Trends Analysis

2 Company Profiles

2.1 Menarini-Silicon Biosystems

2.1.1 Menarini-Silicon Biosystems Details

2.1.2 Menarini-Silicon Biosystems Major Business

2.1.3 Menarini-Silicon Biosystems Circulating Tumor Cells Product and Solutions

2.1.4 Menarini-Silicon Biosystems Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Menarini-Silicon Biosystems Recent Developments and Future Plans

2.2 Qiagen (Adnagen)

2.2.1 Qiagen (Adnagen) Details

2.2.2 Qiagen (Adnagen) Major Business

2.2.3 Qiagen (Adnagen) Circulating Tumor Cells Product and Solutions

2.2.4 Qiagen (Adnagen) Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Qiagen (Adnagen) Recent Developments and Future Plans

2.3 Advanced Cell Diagnostics

2.3.1 Advanced Cell Diagnostics Details

2.3.2 Advanced Cell Diagnostics Major Business

2.3.3 Advanced Cell Diagnostics Circulating Tumor Cells Product and Solutions

2.3.4 Advanced Cell Diagnostics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Advanced Cell Diagnostics Recent Developments and Future Plans

2.4 ApoCell

2.4.1 ApoCell Details

2.4.2 ApoCell Major Business

2.4.3 ApoCell Circulating Tumor Cells Product and Solutions

2.4.4 ApoCell Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 ApoCell Recent Developments and Future Plans

2.5 Epic Sciences

2.5.1 Epic Sciences Details

2.5.2 Epic Sciences Major Business

2.5.3 Epic Sciences Circulating Tumor Cells Product and Solutions

2.5.4 Epic Sciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Epic Sciences Recent Developments and Future Plans

2.6 Greiner Bio-one GmbH

2.6.1 Greiner Bio-one GmbH Details

2.6.2 Greiner Bio-one GmbH Major Business

2.6.3 Greiner Bio-one GmbH Circulating Tumor Cells Product and Solutions

2.6.4 Greiner Bio-one GmbH Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Greiner Bio-one GmbH Recent Developments and Future Plans

2.7 Cynvenio

2.7.1 Cynvenio Details

2.7.2 Cynvenio Major Business

2.7.3 Cynvenio Circulating Tumor Cells Product and Solutions

2.7.4 Cynvenio Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Cynvenio Recent Developments and Future Plans

2.8 SurExamBio-Tech

2.8.1 SurExamBio-Tech Details

2.8.2 SurExamBio-Tech Major Business

2.8.3 SurExamBio-Tech Circulating Tumor Cells Product and Solutions

2.8.4 SurExamBio-Tech Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 SurExamBio-Tech Recent Developments and Future Plans

2.9 Fluxion Biosciences

2.9.1 Fluxion Biosciences Details

2.9.2 Fluxion Biosciences Major Business

2.9.3 Fluxion Biosciences Circulating Tumor Cells Product and Solutions

2.9.4 Fluxion Biosciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Fluxion Biosciences Recent Developments and Future Plans

2.10 Ikonisys

2.10.1 Ikonisys Details

2.10.2 Ikonisys Major Business

2.10.3 Ikonisys Circulating Tumor Cells Product and Solutions

2.10.4 Ikonisys Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Ikonisys Recent Developments and Future Plans

2.11 Hangzhou Watson Biotech

2.11.1 Hangzhou Watson Biotech Details

2.11.2 Hangzhou Watson Biotech Major Business

2.11.3 Hangzhou Watson Biotech Circulating Tumor Cells Product and Solutions

2.11.4 Hangzhou Watson Biotech Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Hangzhou Watson Biotech Recent Developments and Future Plans

2.12 Biocept

2.12.1 Biocept Details

2.12.2 Biocept Major Business

2.12.3 Biocept Circulating Tumor Cells Product and Solutions

2.12.4 Biocept Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Biocept Recent Developments and Future Plans

2.13 CytoTrack

2.13.1 CytoTrack Details

2.13.2 CytoTrack Major Business

2.13.3 CytoTrack Circulating Tumor Cells Product and Solutions

2.13.4 CytoTrack Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 CytoTrack Recent Developments and Future Plans

2.14 Guangzhou Wondfo Biotech

2.14.1 Guangzhou Wondfo Biotech Details

2.14.2 Guangzhou Wondfo Biotech Major Business

2.14.3 Guangzhou Wondfo Biotech Circulating Tumor Cells Product and Solutions

2.14.4 Guangzhou Wondfo Biotech Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Guangzhou Wondfo Biotech Recent Developments and Future Plans

2.15 Celsee

2.15.1 Celsee Details

2.15.2 Celsee Major Business

2.15.3 Celsee Circulating Tumor Cells Product and Solutions

2.15.4 Celsee Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Celsee Recent Developments and Future Plans

2.16 Clearbridge Biomedics

2.16.1 Clearbridge Biomedics Details

2.16.2 Clearbridge Biomedics Major Business

2.16.3 Clearbridge Biomedics Circulating Tumor Cells Product and Solutions

2.16.4 Clearbridge Biomedics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16.5 Clearbridge Biomedics Recent Developments and Future Plans

2.17 ANGLE plc

2.17.1 ANGLE plc Details

2.17.2 ANGLE plc Major Business

2.17.3 ANGLE plc Circulating Tumor Cells Product and Solutions

2.17.4 ANGLE plc Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.17.5 ANGLE plc Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Circulating Tumor Cells Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Circulating Tumor Cells Players Market Share in 2021

3.2.2 Top 10 Circulating Tumor Cells Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Circulating Tumor Cells Players Head Office, Products and Services Provided

3.4 Circulating Tumor Cells Mergers & Acquisitions

3.5 Circulating Tumor Cells New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Circulating Tumor Cells Revenue and Market Share by Type (2017-2022)

4.2 Global Circulating Tumor Cells Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Circulating Tumor Cells Revenue Market Share by Application (2017-2022)

5.2 Global Circulating Tumor Cells Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Circulating Tumor Cells Revenue by Type (2017-2028)

6.2 North America Circulating Tumor Cells Revenue by Application (2017-2028)

6.3 North America Circulating Tumor Cells Market Size by Country

6.3.1 North America Circulating Tumor Cells Revenue by Country (2017-2028)

6.3.2 United States Circulating Tumor Cells Market Size and Forecast (2017-2028)

6.3.3 Canada Circulating Tumor Cells Market Size and Forecast (2017-2028)

6.3.4 Mexico Circulating Tumor Cells Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Circulating Tumor Cells Revenue by Type (2017-2028)

7.2 Europe Circulating Tumor Cells Revenue by Application (2017-2028)

7.3 Europe Circulating Tumor Cells Market Size by Country

7.3.1 Europe Circulating Tumor Cells Revenue by Country (2017-2028)

7.3.2 Germany Circulating Tumor Cells Market Size and Forecast (2017-2028)

7.3.3 France Circulating Tumor Cells Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Circulating Tumor Cells Market Size and Forecast (2017-2028)

7.3.5 Russia Circulating Tumor Cells Market Size and Forecast (2017-2028)

7.3.6 Italy Circulating Tumor Cells Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Circulating Tumor Cells Revenue by Type (2017-2028)

8.2 Asia-Pacific Circulating Tumor Cells Revenue by Application (2017-2028)

8.3 Asia-Pacific Circulating Tumor Cells Market Size by Region

8.3.1 Asia-Pacific Circulating Tumor Cells Revenue by Region (2017-2028)

8.3.2 China Circulating Tumor Cells Market Size and Forecast (2017-2028)

8.3.3 Japan Circulating Tumor Cells Market Size and Forecast (2017-2028)

8.3.4 South Korea Circulating Tumor Cells Market Size and Forecast (2017-2028)

8.3.5 India Circulating Tumor Cells Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Circulating Tumor Cells Market Size and Forecast (2017-2028)

8.3.7 Australia Circulating Tumor Cells Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Circulating Tumor Cells Revenue by Type (2017-2028)

9.2 South America Circulating Tumor Cells Revenue by Application (2017-2028)

9.3 South America Circulating Tumor Cells Market Size by Country

9.3.1 South America Circulating Tumor Cells Revenue by Country (2017-2028)

9.3.2 Brazil Circulating Tumor Cells Market Size and Forecast (2017-2028)

9.3.3 Argentina Circulating Tumor Cells Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Circulating Tumor Cells Revenue by Type (2017-2028)

10.2 Middle East & Africa Circulating Tumor Cells Revenue by Application (2017-2028)

10.3 Middle East & Africa Circulating Tumor Cells Market Size by Country

10.3.1 Middle East & Africa Circulating Tumor Cells Revenue by Country (2017-2028)

10.3.2 Turkey Circulating Tumor Cells Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Circulating Tumor Cells Market Size and Forecast (2017-2028)

10.3.4 UAE Circulating Tumor Cells Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Circulating Tumor Cells Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Circulating Tumor Cells Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Circulating Tumor Cells Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Circulating Tumor Cells Revenue (USD Million) by Region (2017-2022)

Table 5. Global Circulating Tumor Cells Revenue Market Share by Region (2023-2028)

Table 6. Menarini-Silicon Biosystems Corporate Information, Head Office, and Major Competitors

Table 7. Menarini-Silicon Biosystems Major Business

Table 8. Menarini-Silicon Biosystems Circulating Tumor Cells Product and Solutions

Table 9. Menarini-Silicon Biosystems Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Qiagen (Adnagen) Corporate Information, Head Office, and Major Competitors

Table 11. Qiagen (Adnagen) Major Business

Table 12. Qiagen (Adnagen) Circulating Tumor Cells Product and Solutions

Table 13. Qiagen (Adnagen) Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Advanced Cell Diagnostics Corporate Information, Head Office, and Major Competitors

Table 15. Advanced Cell Diagnostics Major Business

Table 16. Advanced Cell Diagnostics Circulating Tumor Cells Product and Solutions

Table 17. Advanced Cell Diagnostics Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. ApoCell Corporate Information, Head Office, and Major Competitors

Table 19. ApoCell Major Business

Table 20. ApoCell Circulating Tumor Cells Product and Solutions

Table 21. ApoCell Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Epic Sciences Corporate Information, Head Office, and Major Competitors

Table 23. Epic Sciences Major Business

Table 24. Epic Sciences Circulating Tumor Cells Product and Solutions

Table 25. Epic Sciences Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Greiner Bio-one GmbH Corporate Information, Head Office, and Major Competitors

Table 27. Greiner Bio-one GmbH Major Business

Table 28. Greiner Bio-one GmbH Circulating Tumor Cells Product and Solutions

Table 29. Greiner Bio-one GmbH Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Cynvenio Corporate Information, Head Office, and Major Competitors

Table 31. Cynvenio Major Business

Table 32. Cynvenio Circulating Tumor Cells Product and Solutions

Table 33. Cynvenio Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. SurExamBio-Tech Corporate Information, Head Office, and Major Competitors

Table 35. SurExamBio-Tech Major Business

Table 36. SurExamBio-Tech Circulating Tumor Cells Product and Solutions

Table 37. SurExamBio-Tech Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Fluxion Biosciences Corporate Information, Head Office, and Major Competitors

Table 39. Fluxion Biosciences Major Business

Table 40. Fluxion Biosciences Circulating Tumor Cells Product and Solutions

Table 41. Fluxion Biosciences Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Ikonisys Corporate Information, Head Office, and Major Competitors

Table 43. Ikonisys Major Business

Table 44. Ikonisys Circulating Tumor Cells Product and Solutions

Table 45. Ikonisys Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Hangzhou Watson Biotech Corporate Information, Head Office, and Major Competitors

Table 47. Hangzhou Watson Biotech Major Business

Table 48. Hangzhou Watson Biotech Circulating Tumor Cells Product and Solutions

Table 49. Hangzhou Watson Biotech Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Biocept Corporate Information, Head Office, and Major Competitors

Table 51. Biocept Major Business

Table 52. Biocept Circulating Tumor Cells Product and Solutions

Table 53. Biocept Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. CytoTrack Corporate Information, Head Office, and Major Competitors

Table 55. CytoTrack Major Business

Table 56. CytoTrack Circulating Tumor Cells Product and Solutions

Table 57. CytoTrack Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Guangzhou Wondfo Biotech Corporate Information, Head Office, and Major Competitors

Table 59. Guangzhou Wondfo Biotech Major Business

Table 60. Guangzhou Wondfo Biotech Circulating Tumor Cells Product and Solutions

Table 61. Guangzhou Wondfo Biotech Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Celsee Corporate Information, Head Office, and Major Competitors

Table 63. Celsee Major Business

Table 64. Celsee Circulating Tumor Cells Product and Solutions

Table 65. Celsee Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Clearbridge Biomedics Corporate Information, Head Office, and Major Competitors

Table 67. Clearbridge Biomedics Major Business

Table 68. Clearbridge Biomedics Circulating Tumor Cells Product and Solutions

Table 69. Clearbridge Biomedics Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 70. ANGLE plc Corporate Information, Head Office, and Major Competitors

Table 71. ANGLE plc Major Business

Table 72. ANGLE plc Circulating Tumor Cells Product and Solutions

Table 73. ANGLE plc Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 74. Global Circulating Tumor Cells Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 75. Global Circulating Tumor Cells Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 76. Breakdown of Circulating Tumor Cells by Company Type (Tier 1, Tier 2 and Tier 3)

Table 77. Circulating Tumor Cells Players Head Office, Products and Services Provided

Table 78. Circulating Tumor Cells Mergers & Acquisitions in the Past Five Years

Table 79. Circulating Tumor Cells New Entrants and Expansion Plans

Table 80. Global Circulating Tumor Cells Revenue (USD Million) by Type (2017-2022)

Table 81. Global Circulating Tumor Cells Revenue Share by Type (2017-2022)

Table 82. Global Circulating Tumor Cells Revenue Forecast by Type (2023-2028)

Table 83. Global Circulating Tumor Cells Revenue by Application (2017-2022)

Table 84. Global Circulating Tumor Cells Revenue Forecast by Application (2023-2028)

Table 85. North America Circulating Tumor Cells Revenue by Type (2017-2022) & (USD Million)

Table 86. North America Circulating Tumor Cells Revenue by Type (2023-2028) & (USD Million)

Table 87. North America Circulating Tumor Cells Revenue by Application (2017-2022) & (USD Million)

Table 88. North America Circulating Tumor Cells Revenue by Application (2023-2028) & (USD Million)

Table 89. North America Circulating Tumor Cells Revenue by Country (2017-2022) & (USD Million)

Table 90. North America Circulating Tumor Cells Revenue by Country (2023-2028) & (USD Million)

Table 91. Europe Circulating Tumor Cells Revenue by Type (2017-2022) & (USD Million)

Table 92. Europe Circulating Tumor Cells Revenue by Type (2023-2028) & (USD Million)

Table 93. Europe Circulating Tumor Cells Revenue by Application (2017-2022) & (USD Million)

Table 94. Europe Circulating Tumor Cells Revenue by Application (2023-2028) & (USD Million)

Table 95. Europe Circulating Tumor Cells Revenue by Country (2017-2022) & (USD Million)

Table 96. Europe Circulating Tumor Cells Revenue by Country (2023-2028) & (USD Million)

Table 97. Asia-Pacific Circulating Tumor Cells Revenue by Type (2017-2022) & (USD Million)

Table 98. Asia-Pacific Circulating Tumor Cells Revenue by Type (2023-2028) & (USD Million)

Table 99. Asia-Pacific Circulating Tumor Cells Revenue by Application (2017-2022) & (USD Million)

Table 100. Asia-Pacific Circulating Tumor Cells Revenue by Application (2023-2028) & (USD Million)

Table 101. Asia-Pacific Circulating Tumor Cells Revenue by Region (2017-2022) & (USD Million)

Table 102. Asia-Pacific Circulating Tumor Cells Revenue by Region (2023-2028) & (USD Million)

Table 103. South America Circulating Tumor Cells Revenue by Type (2017-2022) & (USD Million)

Table 104. South America Circulating Tumor Cells Revenue by Type (2023-2028) & (USD Million)

Table 105. South America Circulating Tumor Cells Revenue by Application (2017-2022) & (USD Million)

Table 106. South America Circulating Tumor Cells Revenue by Application (2023-2028) & (USD Million)

Table 107. South America Circulating Tumor Cells Revenue by Country (2017-2022) & (USD Million)

Table 108. South America Circulating Tumor Cells Revenue by Country (2023-2028) & (USD Million)

Table 109. Middle East & Africa Circulating Tumor Cells Revenue by Type (2017-2022) & (USD Million)

Table 110. Middle East & Africa Circulating Tumor Cells Revenue by Type (2023-2028) & (USD Million)

Table 111. Middle East & Africa Circulating Tumor Cells Revenue by Application (2017-2022) & (USD Million)

Table 112. Middle East & Africa Circulating Tumor Cells Revenue by Application (2023-2028) & (USD Million)

Table 113. Middle East & Africa Circulating Tumor Cells Revenue by Country (2017-2022) & (USD Million)

Table 114. Middle East & Africa Circulating Tumor Cells Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Circulating Tumor Cells Picture

Figure 2. Global Circulating Tumor Cells Revenue Market Share by Type in 2021

Figure 3. CTC Enrichment

Figure 4. CTC Detection

Figure 5. CTC Analysis

Figure 6. Circulating Tumor Cells Revenue Market Share by Application in 2021

Figure 7. Breast Cancer Picture

Figure 8. Prostate Cancer Picture

Figure 9. Colorectal Cancer Picture

Figure 10. Lung Cancer Picture

Figure 11. Others Picture

Figure 12. Global Circulating Tumor Cells Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 13. Global Circulating Tumor Cells Revenue and Forecast (2017-2028) & (USD Million)

Figure 14. Global Circulating Tumor Cells Revenue Market Share by Region (2017-2028)

Figure 15. Global Circulating Tumor Cells Revenue Market Share by Region in 2021

Figure 16. North America Circulating Tumor Cells Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Europe Circulating Tumor Cells Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Asia-Pacific Circulating Tumor Cells Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. South America Circulating Tumor Cells Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Middle East and Africa Circulating Tumor Cells Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Circulating Tumor Cells Market Drivers

Figure 22. Circulating Tumor Cells Market Restraints

Figure 23. Circulating Tumor Cells Market Trends

Figure 24. Menarini-Silicon Biosystems Recent Developments and Future Plans

Figure 25. Qiagen (Adnagen) Recent Developments and Future Plans

Figure 26. Advanced Cell Diagnostics Recent Developments and Future Plans

Figure 27. ApoCell Recent Developments and Future Plans

Figure 28. Epic Sciences Recent Developments and Future Plans

Figure 29. Greiner Bio-one GmbH Recent Developments and Future Plans

Figure 30. Cynvenio Recent Developments and Future Plans

Figure 31. SurExamBio-Tech Recent Developments and Future Plans

Figure 32. Fluxion Biosciences Recent Developments and Future Plans

Figure 33. Ikonisys Recent Developments and Future Plans

Figure 34. Hangzhou Watson Biotech Recent Developments and Future Plans

Figure 35. Biocept Recent Developments and Future Plans

Figure 36. CytoTrack Recent Developments and Future Plans

Figure 37. Guangzhou Wondfo Biotech Recent Developments and Future Plans

Figure 38. Celsee Recent Developments and Future Plans

Figure 39. Clearbridge Biomedics Recent Developments and Future Plans

Figure 40. ANGLE plc Recent Developments and Future Plans

Figure 41. Global Circulating Tumor Cells Revenue Share by Players in 2021

Figure 42. Circulating Tumor Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 43. Global Top 3 Players Circulating Tumor Cells Revenue Market Share in 2021

Figure 44. Global Top 10 Players Circulating Tumor Cells Revenue Market Share in 2021

Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 46. Global Circulating Tumor Cells Revenue Share by Type in 2021

Figure 47. Global Circulating Tumor Cells Market Share Forecast by Type (2023-2028)

Figure 48. Global Circulating Tumor Cells Revenue Share by Application in 2021

Figure 49. Global Circulating Tumor Cells Market Share Forecast by Application (2023-2028)

Figure 50. North America Circulating Tumor Cells Sales Market Share by Type (2017-2028)

Figure 51. North America Circulating Tumor Cells Sales Market Share by Application (2017-2028)

Figure 52. North America Circulating Tumor Cells Revenue Market Share by Country (2017-2028)

Figure 53. United States Circulating Tumor Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Canada Circulating Tumor Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Mexico Circulating Tumor Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Europe Circulating Tumor Cells Sales Market Share by Type (2017-2028)

Figure 57. Europe Circulating Tumor Cells Sales Market Share by Application (2017-2028)

Figure 58. Europe Circulating Tumor Cells Revenue Market Share by Country (2017-2028)

Figure 59. Germany Circulating Tumor Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. France Circulating Tumor Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. United Kingdom Circulating Tumor Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Russia Circulating Tumor Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Italy Circulating Tumor Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Asia-Pacific Circulating Tumor Cells Sales Market Share by Type (2017-2028)

Figure 65. Asia-Pacific Circulating Tumor Cells Sales Market Share by Application (2017-2028)

Figure 66. Asia-Pacific Circulating Tumor Cells Revenue Market Share by Region (2017-2028)

Figure 67. China Circulating Tumor Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Japan Circulating Tumor Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. South Korea Circulating Tumor Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. India Circulating Tumor Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Southeast Asia Circulating Tumor Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Australia Circulating Tumor Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. South America Circulating Tumor Cells Sales Market Share by Type (2017-2028)

Figure 74. South America Circulating Tumor Cells Sales Market Share by Application (2017-2028)

Figure 75. South America Circulating Tumor Cells Revenue Market Share by Country (2017-2028)

Figure 76. Brazil Circulating Tumor Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Argentina Circulating Tumor Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. Middle East and Africa Circulating Tumor Cells Sales Market Share by Type (2017-2028)

Figure 79. Middle East and Africa Circulating Tumor Cells Sales Market Share by Application (2017-2028)

Figure 80. Middle East and Africa Circulating Tumor Cells Revenue Market Share by Country (2017-2028)

Figure 81. Turkey Circulating Tumor Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 82. Saudi Arabia Circulating Tumor Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 83. UAE Circulating Tumor Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 84. Methodology

Figure 85. Research Process and Data Source